SG Americas Securities’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15M Sell
56,352
-11,730
-17% -$3.18M 0.02% 644
2025
Q4
$17.1M Buy
68,082
+47,165
+225% +$12.5M 0.02% 556
2025
Q3
$6M Buy
20,917
+17,723
+555% +$4.75M 0.02% 448
2025
Q2
$838K Sell
3,194
-22,769
-88% -$5.54M ﹤0.01% 1301
2025
Q1
$6.04M Buy
25,963
+24,996
+2,585% +$6.07M 0.02% 420
2024
Q4
$222K Sell
967
-88,021
-99% -$20.2M ﹤0.01% 2058
2024
Q3
$19.9M Buy
88,988
+57,553
+183% +$12.6M 0.07% 163
2024
Q2
$6.4M Buy
31,435
+8,218
+35% +$1.67M 0.04% 449
2024
Q1
$5.07M Buy
23,217
+17,156
+283% +$3.78M 0.02% 544
2023
Q4
$1.38M Buy
6,061
+4,706
+347% +$989K 0.01% 860
2023
Q3
$272K Sell
1,355
-12,294
-90% -$2.59M ﹤0.01% 2132
2023
Q2
$2.83M Buy
+13,649
New +$2.65M 0.02% 584
2022
Q4
Sell
-9,612
Closed -$1.69M 3230
2022
Q3
$1.69M Buy
9,612
+6,529
+212% +$1.34M 0.02% 676
2022
Q2
$621K Sell
3,083
-7,791
-72% -$1.66M 0.01% 1760
2022
Q1
$2.46M Buy
10,874
+3,302
+44% +$777K 0.02% 757
2021
Q4
$2.04M Sell
7,572
-7,227
-49% -$1.79M 0.01% 1070
2021
Q3
$3.58M Sell
14,799
-19,142
-56% -$4.82M 0.02% 769
2021
Q2
$8.04M Buy
33,941
+25,689
+311% +$5.85M 0.04% 425
2021
Q1
$1.81M Sell
8,252
-17,818
-68% -$3.58M 0.01% 1117
2020
Q4
$4.56M Buy
26,070
+21,939
+531% +$3.79M 0.02% 554
2020
Q3
$668K Sell
4,131
-3,581
-46% -$568K ﹤0.01% 1445
2020
Q2
$1.1M Sell
7,712
-13,179
-63% -$1.82M 0.01% 1328
2020
Q1
$2.27M Sell
20,891
-20,059
-49% -$2.89M 0.02% 731
2019
Q4
$5.95M Buy
40,950
+16,647
+68% +$2.4M 0.05% 330
2019
Q3
$3.51M Sell
24,303
-2,183
-8% -$319K 0.03% 613
2019
Q2
$3.93M Buy
26,486
+23,467
+777% +$3.27M 0.03% 653
2019
Q1
$397K Sell
3,019
-10,781
-78% -$1.33M ﹤0.01% 2036
2018
Q4
$1.5M Sell
13,800
-1,998
-13% -$268K 0.01% 1063
2018
Q3
$2.36M Sell
15,798
-3,917
-20% -$596K 0.02% 1042
2018
Q2
$3.04M Sell
19,715
-14,312
-42% -$2.16M 0.03% 682
2018
Q1
$4.73M Buy
34,027
+18,261
+116% +$2.68M 0.04% 447
2017
Q4
$2.16M Buy
15,766
+2,062
+15% +$272K 0.02% 830
2017
Q3
$1.78M Sell
13,704
-646
-5% -$86.2K 0.02% 870
2017
Q2
$1.9M Sell
14,350
-11,662
-45% -$1.43M 0.02% 930
2017
Q1
$3.21M Buy
26,012
+2,122
+9% +$251K 0.03% 616
2016
Q4
$2.63M Buy
23,890
+19,214
+411% +$2.13M 0.02% 771
2016
Q3
$552K Sell
4,676
-4,955
-51% -$584K 0.01% 1619
2016
Q2
$1.08M Sell
9,631
-5,198
-35% -$559K 0.01% 1246
2016
Q1
$1.49M Buy
14,829
+2,782
+23% +$267K 0.01% 1056
2015
Q4
$1.28M Sell
12,047
-4,350
-27% -$449K 0.01% 983
2015
Q3
$1.53M Buy
16,397
+7,233
+79% +$748K 0.01% 703
2015
Q2
$954K Buy
9,164
+604
+7% +$62.9K 0.01% 1099
2015
Q1
$927K Sell
8,560
-33,353
-80% -$3.43M 0.01% 1171
2014
Q4
$3.88M Sell
41,913
-35,403
-46% -$3.13M 0.02% 703
2014
Q3
$6.76M Buy
77,316
+53,478
+224% +$4.83M 0.04% 410
2014
Q2
$2.1M Sell
23,838
-20,592
-46% -$1.78M 0.01% 966
2014
Q1
$3.75M Sell
44,430
-108,968
-71% -$8.69M 0.02% 721
2013
Q4
$12M Buy
153,398
+126,742
+475% +$10.8M 0.05% 369
2013
Q3
$2.27M Sell
26,656
-15,774
-37% -$1.33M 0.01% 895
2013
Q2
$3.65M Buy
+42,430
New +$3.52M 0.02% 670

Other funds holding LH

SG Americas Securities's LH Position: Q1 2026 in Review

SG Americas Securities reduced its Labcorp (LH) stake by 17% in Q1 2026, selling an estimated $3.18M and leaving 56,352 shares worth $15M. The position accounts for 0.02% of the portfolio, ranked #644.

SG Americas Securities first reported a position in LH in Q2 2013 and has held it in 50 quarters since. The position peaked at $19.9M in Q3 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • SG Americas Securities held 56,352 shares of Labcorp worth $15M as of Q1 2026.
  • SG Americas Securities sold 11,730 Labcorp shares in Q1 2026, an estimated $3.18M.
  • Labcorp made up 0.02% of SG Americas Securities's portfolio in Q1 2026, its #644 holding.
  • SG Americas Securities first reported a position in Labcorp in Q2 2013 and has held it in 50 quarters since.
  • SG Americas Securities's Labcorp position peaked at $19.9M in Q3 2024.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.